Even as a host of companies rush to create COVID-19 vaccines, there’s another looming challenge: how to safely and quickly distribute them. Officials at Honeywell (NYSE:HON) think they have one potential solution with their Aclar Edge bottles and vials, touted as a safer alternative to glass packaging for pharmaceutical products. Kori Anderson, Honeywell’s healthcare packaging GM,…
Kodak stock down 30% after pharma deal put on hold
Shares of Eastman Kodak (NYSE: KODK) were down more than 30% near the close of trading today after a tweet from the U.S. International Development Finance Corp. said a $765 million loan for domestic pharmaceutical manufacturing is on hold. The Aug. 7 tweet said: “On July 28, we signed a Letter of Interest with Eastman…
Trump signs executive order to help reshore pharmaceutical manufacturing
President Donald Trump recently signed an executive order meant to encourage the reshoring of pharmaceutical manufacturing to the U.S. The executive order, signed Aug. 6, includes “buy American” provisions for U.S. government agencies’ procurement of essential medicines and reduces regulatory provisions. The Secretary of Health and Human Services and FDA commissioner, consistent with applicable law,…
Hologic spending more than $50M to expand COVID-19 test production
Hologic (NSDQ:HOLX) is spending $50 million — including $14 million during its most recent quarter — to boost its production of COVID-19 tests. The U.S. government is providing $7.6 million to support the effort. Hologic’s business partner Stratec is also doubling the production of the Panther instruments that run Hologic assays. Get the full story on our sister site…
How Seeq software can help predict chromatography column failure
It’s possible to use advanced analytics to predict biopharmaceutical failures, allowing corrective action to be taken before batches are lost or quality is degraded. A Seeq expert explains. Joe Reckamp, Seeq The biopharmaceutical industry uses chromatography processes extensively. Along with filtration, they are one of the most important separation and purification unit operations. These two…
Moderna to make its COVID-19 vaccine candidate in Spain
Moderna (NSDQ:MRNA) announced today that Laboratorios Farmacéuticos Rovi has agreed to make Moderna’s COVID-19 vaccine candidate in its Madrid, Spain facility. The contract for large-scale, commercial fill-finish manufacturing in Spain is but the latest that Moderna has secured as it moves forward with Phase 3 of the clinical trial for its COVID-19 vaccine candidate. Moderna in…
Stevanato Group lauches modular, robotic pharma inspection system with AI
The Stevanto Group (Piombino Dese, Italy) announced today that it is launching a modular, robotic inspection system that incorporates AI with accrued machine learning capabilities. The company boasts that its Vision Robot Unit (VRU) is able to automatically and reliably inspect both cosmetic and particle properties without human intervention. The VRU has a patent-pending design…
U.S. investing $42m to boost BD syringe and needle production
HHS’s Biomedical Advanced Research and Development Authority is helping BD expand operations and manufacturing capacity in Nebraska to boost syringe and needle supplies for an eventual COVID-19 vaccine. Becton Dickinson (NYSE:BDX) said today that the total project will cost $70 million, with BARDA providing $42 million. The company expects the new capacity to be online within…
Legacy Pharmaceutical Packaging buys facility to expand third-party logistics
Legacy Pharmaceutical Packaging recently announced that it has bought a 215,000-square-foot open-space facility near its St. Louis area headquarters to support widescale third-party logistics and distribution services. The new facility, announced last week, nearly doubles Legacy’s total footprint to more than 500,000 square feet. The new space allows Legacy Pharmaceutical Packaging to significantly grow its…
Real estate firms tout former Bristol-Myers Squibb facility as an ‘innovation campus’
Lincoln Equities Group and H.I.G. Realty Partners announced today that they’ve acquired the 1.2 million-square-foot life sciences campus that Bristol-Myers Squibb owned outside Princeton, N.J. Brokerage firm JLL is helping the real estate outfits market the 433-acre “Princeton West Innovation Campus” in Hopewell, N.J., to life sciences companies as a secure, multipurpose research and development…